{"altmetric_id":3665483,"counts":{"readers":{"mendeley":3,"citeulike":0,"connotea":0},"total":{"posts_count":1},"wikipedia":{"unique_users_count":1,"unique_users":["en:40240435"],"posts_count":1}},"citation":{"altmetric_jid":"4f6fa4e93cf058f610002497","authors":["Shri N. Giri","Mohammed Ali Al-Bayati","Xiaogu Du","Edward Schelegle","F. Charles Mohr","Solomon B. Margolin"],"doi":"10.1007\/s00280-003-0703-z","first_seen_on":"2015-02-15T13:12:05+00:00","issns":["1432-0843"],"journal":"Cancer Chemotherapy & Pharmacology","last_mentioned_on":1376499722,"links":["http:\/\/dx.doi.org\/10.1007\/s00280-003-0703-z"],"pdf_url":"http:\/\/link.springer.com\/content\/pdf\/10.1007%2Fs00280-003-0703-z.pdf","pubdate":"2003-10-15T00:00:00+00:00","publisher":"Springer-Verlag","publisher_subjects":[{"name":"Pharmacology And Pharmaceutical Sciences","scheme":"era"},{"name":"Medicine","scheme":"springer"}],"scopus_subjects":["Life Sciences","Medicine","Health Sciences","Pharmacology, Toxicology and Pharmaceutics","Biochemistry, Genetics and Molecular Biology"],"subjects":["neoplasms","antineoplasticagents"],"title":"Amelioration of doxorubicin-induced cardiac and renal toxicity by pirfenidone in rats","type":"article","mendeley_url":"http:\/\/www.mendeley.com\/research\/amelioration-doxorubicininduced-cardiac-renal-toxicity-pirfenidone-rats"},"altmetric_score":{"score":3,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":3},"context_for_score":{"all":{"total_number_of_other_articles":3616387,"mean":4.9300280987737,"rank":815283,"this_scored_higher_than_pct":62,"this_scored_higher_than":2277410,"rank_type":"exact","sample_size":3616387,"percentile":62},"similar_age_3m":{"total_number_of_other_articles":95293,"mean":7.1844925702053,"rank":24090,"this_scored_higher_than_pct":73,"this_scored_higher_than":70124,"rank_type":"exact","sample_size":95293,"percentile":73},"this_journal":{"total_number_of_other_articles":364,"mean":2.2731570247934,"rank":45,"this_scored_higher_than_pct":69,"this_scored_higher_than":252,"rank_type":"exact","sample_size":364,"percentile":69},"similar_age_this_journal_3m":{"total_number_of_other_articles":15,"mean":1.4074285714286,"rank":2,"this_scored_higher_than_pct":86,"this_scored_higher_than":13,"rank_type":"exact","sample_size":15,"percentile":86}}},"demographics":{"users":{"mendeley":{"by_status":{"Unspecified":1,"Student  > Master":2},"by_discipline":{"Medicine and Dentistry":1,"Unspecified":1,"Pharmacology, Toxicology and Pharmaceutical Science":1}}}},"posts":{"wikipedia":[{"title":"Mohammed Al-Bayati","url":"http:\/\/en.wikipedia.org\/?diff=prev&oldid=568529987#altmetric_citation_1","license":"public","citation_ids":[3665483],"posted_on":"2013-08-14T17:02:02+00:00","summary":"Mohammed Ali Al-Bayati, PhD, DABT, DABVT is a comparative pathologist and HIV\/AIDS denialist, and member of the board of Alive and Well AIDS Alternatives, who is known for his involvement in the death of Eliza Jane Scovill.","page_url":"http:\/\/en.wikipedia.org\/?curid=40240435","wiki_lang":"en","author":{"name":"Everymorning","url":"http:\/\/en.wikipedia.org\/wiki\/User:Everymorning"}}]}}